Short and long-term advantages of transhiatal and transthoracic oesophageal cancer resection
Abstract Two major surgical strategies to improve survival rates after oesophagectomy for oesophageal cancer have emerged during the past decades; (limited) transhiatal oesophagectomy and (extended) transthoracic oesophagectomy with two-field lymphadenectomy. This overview describes short and long-t...
Gespeichert in:
Veröffentlicht in: | European journal of surgical oncology 2009-08, Vol.35 (8), p.793-797 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 797 |
---|---|
container_issue | 8 |
container_start_page | 793 |
container_title | European journal of surgical oncology |
container_volume | 35 |
creator | Omloo, J.M.T Law, S.Y.K Launois, B Le Prisé, E Wong, J van Berge Henegouwen, M.I van Lanschot, J.J.B |
description | Abstract Two major surgical strategies to improve survival rates after oesophagectomy for oesophageal cancer have emerged during the past decades; (limited) transhiatal oesophagectomy and (extended) transthoracic oesophagectomy with two-field lymphadenectomy. This overview describes short and long-term advantages of these two strategies. In the short term, transhiatal oesophagectomy is accompanied by less morbidity. In the long term, this strategy is only preferable for patients with tumours located at the gastro-oesophageal junction, without involved lymph nodes in the proximal compartment of the chest. For patients with tumours located in the oesophagus, the transthoracic route with extended lymphadenectomy is probably preferred, because of improved long-term survival. |
doi_str_mv | 10.1016/j.ejso.2008.10.005 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67425436</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S074879830801799X</els_id><sourcerecordid>67425436</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-f594aa41c074dac1fcf02486d794afc27a36d3048f65b72d290bf75f5419d97f3</originalsourceid><addsrcrecordid>eNp9kVFrFDEUhYModlv9Az7IPPk2600mM5mACFK0CgUfasEHIWSTm27G2WRNsoX--2a6C4IPPoWcnHO4-S4hbyisKdDh_bTGKcc1AxirsAbon5EV7TvWMtqL52QFgo-tkGN3Rs5zngBAdkK-JGdUAoWh4yvy62YbU2l0sM0cw11bMO0abe91KPoOcxNdU5IOeet10fOT7-leakwbb5qIOe631VtfjQ4GU5Mwoyk-hlfkhdNzxten84Lcfvn84_Jre_396tvlp-vWcJCldb3kWnNq6rxWG-qMA8bHwYqqO8OE7gbbAR_d0G8Es0zCxone9ZxKK4XrLsi7Y-8-xT8HzEXtfDY4zzpgPGQ1CM563g3VyI5Gk2LOCZ3aJ7_T6UFRUAtTNamFqVqYLlplWkNvT-2HzQ7t38gJYjV8OBqw_vHeY1LZeKworE8VhLLR_7__4z9xM_vgjZ5_4wPmKR5SqPQUVZkpUDfLVpelwghUSPmzewStvp5q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67425436</pqid></control><display><type>article</type><title>Short and long-term advantages of transhiatal and transthoracic oesophageal cancer resection</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Omloo, J.M.T ; Law, S.Y.K ; Launois, B ; Le Prisé, E ; Wong, J ; van Berge Henegouwen, M.I ; van Lanschot, J.J.B</creator><creatorcontrib>Omloo, J.M.T ; Law, S.Y.K ; Launois, B ; Le Prisé, E ; Wong, J ; van Berge Henegouwen, M.I ; van Lanschot, J.J.B</creatorcontrib><description>Abstract Two major surgical strategies to improve survival rates after oesophagectomy for oesophageal cancer have emerged during the past decades; (limited) transhiatal oesophagectomy and (extended) transthoracic oesophagectomy with two-field lymphadenectomy. This overview describes short and long-term advantages of these two strategies. In the short term, transhiatal oesophagectomy is accompanied by less morbidity. In the long term, this strategy is only preferable for patients with tumours located at the gastro-oesophageal junction, without involved lymph nodes in the proximal compartment of the chest. For patients with tumours located in the oesophagus, the transthoracic route with extended lymphadenectomy is probably preferred, because of improved long-term survival.</description><identifier>ISSN: 0748-7983</identifier><identifier>EISSN: 1532-2157</identifier><identifier>DOI: 10.1016/j.ejso.2008.10.005</identifier><identifier>PMID: 19010634</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Advantages ; Esophageal Neoplasms - pathology ; Esophageal Neoplasms - surgery ; Esophagectomy - methods ; Hematology, Oncology and Palliative Medicine ; Humans ; Lymph Node Excision ; Lymphatic Metastasis ; Neoplasm Staging ; Oesophageal cancer ; Surgery ; Survival ; Transhiatal ; Transthoracic</subject><ispartof>European journal of surgical oncology, 2009-08, Vol.35 (8), p.793-797</ispartof><rights>Elsevier Ltd</rights><rights>2008 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-f594aa41c074dac1fcf02486d794afc27a36d3048f65b72d290bf75f5419d97f3</citedby><cites>FETCH-LOGICAL-c409t-f594aa41c074dac1fcf02486d794afc27a36d3048f65b72d290bf75f5419d97f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejso.2008.10.005$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,782,786,3552,27931,27932,46002</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19010634$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Omloo, J.M.T</creatorcontrib><creatorcontrib>Law, S.Y.K</creatorcontrib><creatorcontrib>Launois, B</creatorcontrib><creatorcontrib>Le Prisé, E</creatorcontrib><creatorcontrib>Wong, J</creatorcontrib><creatorcontrib>van Berge Henegouwen, M.I</creatorcontrib><creatorcontrib>van Lanschot, J.J.B</creatorcontrib><title>Short and long-term advantages of transhiatal and transthoracic oesophageal cancer resection</title><title>European journal of surgical oncology</title><addtitle>Eur J Surg Oncol</addtitle><description>Abstract Two major surgical strategies to improve survival rates after oesophagectomy for oesophageal cancer have emerged during the past decades; (limited) transhiatal oesophagectomy and (extended) transthoracic oesophagectomy with two-field lymphadenectomy. This overview describes short and long-term advantages of these two strategies. In the short term, transhiatal oesophagectomy is accompanied by less morbidity. In the long term, this strategy is only preferable for patients with tumours located at the gastro-oesophageal junction, without involved lymph nodes in the proximal compartment of the chest. For patients with tumours located in the oesophagus, the transthoracic route with extended lymphadenectomy is probably preferred, because of improved long-term survival.</description><subject>Advantages</subject><subject>Esophageal Neoplasms - pathology</subject><subject>Esophageal Neoplasms - surgery</subject><subject>Esophagectomy - methods</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Lymph Node Excision</subject><subject>Lymphatic Metastasis</subject><subject>Neoplasm Staging</subject><subject>Oesophageal cancer</subject><subject>Surgery</subject><subject>Survival</subject><subject>Transhiatal</subject><subject>Transthoracic</subject><issn>0748-7983</issn><issn>1532-2157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kVFrFDEUhYModlv9Az7IPPk2600mM5mACFK0CgUfasEHIWSTm27G2WRNsoX--2a6C4IPPoWcnHO4-S4hbyisKdDh_bTGKcc1AxirsAbon5EV7TvWMtqL52QFgo-tkGN3Rs5zngBAdkK-JGdUAoWh4yvy62YbU2l0sM0cw11bMO0abe91KPoOcxNdU5IOeet10fOT7-leakwbb5qIOe631VtfjQ4GU5Mwoyk-hlfkhdNzxten84Lcfvn84_Jre_396tvlp-vWcJCldb3kWnNq6rxWG-qMA8bHwYqqO8OE7gbbAR_d0G8Es0zCxone9ZxKK4XrLsi7Y-8-xT8HzEXtfDY4zzpgPGQ1CM563g3VyI5Gk2LOCZ3aJ7_T6UFRUAtTNamFqVqYLlplWkNvT-2HzQ7t38gJYjV8OBqw_vHeY1LZeKworE8VhLLR_7__4z9xM_vgjZ5_4wPmKR5SqPQUVZkpUDfLVpelwghUSPmzewStvp5q</recordid><startdate>20090801</startdate><enddate>20090801</enddate><creator>Omloo, J.M.T</creator><creator>Law, S.Y.K</creator><creator>Launois, B</creator><creator>Le Prisé, E</creator><creator>Wong, J</creator><creator>van Berge Henegouwen, M.I</creator><creator>van Lanschot, J.J.B</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20090801</creationdate><title>Short and long-term advantages of transhiatal and transthoracic oesophageal cancer resection</title><author>Omloo, J.M.T ; Law, S.Y.K ; Launois, B ; Le Prisé, E ; Wong, J ; van Berge Henegouwen, M.I ; van Lanschot, J.J.B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-f594aa41c074dac1fcf02486d794afc27a36d3048f65b72d290bf75f5419d97f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Advantages</topic><topic>Esophageal Neoplasms - pathology</topic><topic>Esophageal Neoplasms - surgery</topic><topic>Esophagectomy - methods</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Lymph Node Excision</topic><topic>Lymphatic Metastasis</topic><topic>Neoplasm Staging</topic><topic>Oesophageal cancer</topic><topic>Surgery</topic><topic>Survival</topic><topic>Transhiatal</topic><topic>Transthoracic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Omloo, J.M.T</creatorcontrib><creatorcontrib>Law, S.Y.K</creatorcontrib><creatorcontrib>Launois, B</creatorcontrib><creatorcontrib>Le Prisé, E</creatorcontrib><creatorcontrib>Wong, J</creatorcontrib><creatorcontrib>van Berge Henegouwen, M.I</creatorcontrib><creatorcontrib>van Lanschot, J.J.B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Omloo, J.M.T</au><au>Law, S.Y.K</au><au>Launois, B</au><au>Le Prisé, E</au><au>Wong, J</au><au>van Berge Henegouwen, M.I</au><au>van Lanschot, J.J.B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Short and long-term advantages of transhiatal and transthoracic oesophageal cancer resection</atitle><jtitle>European journal of surgical oncology</jtitle><addtitle>Eur J Surg Oncol</addtitle><date>2009-08-01</date><risdate>2009</risdate><volume>35</volume><issue>8</issue><spage>793</spage><epage>797</epage><pages>793-797</pages><issn>0748-7983</issn><eissn>1532-2157</eissn><abstract>Abstract Two major surgical strategies to improve survival rates after oesophagectomy for oesophageal cancer have emerged during the past decades; (limited) transhiatal oesophagectomy and (extended) transthoracic oesophagectomy with two-field lymphadenectomy. This overview describes short and long-term advantages of these two strategies. In the short term, transhiatal oesophagectomy is accompanied by less morbidity. In the long term, this strategy is only preferable for patients with tumours located at the gastro-oesophageal junction, without involved lymph nodes in the proximal compartment of the chest. For patients with tumours located in the oesophagus, the transthoracic route with extended lymphadenectomy is probably preferred, because of improved long-term survival.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>19010634</pmid><doi>10.1016/j.ejso.2008.10.005</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0748-7983 |
ispartof | European journal of surgical oncology, 2009-08, Vol.35 (8), p.793-797 |
issn | 0748-7983 1532-2157 |
language | eng |
recordid | cdi_proquest_miscellaneous_67425436 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Advantages Esophageal Neoplasms - pathology Esophageal Neoplasms - surgery Esophagectomy - methods Hematology, Oncology and Palliative Medicine Humans Lymph Node Excision Lymphatic Metastasis Neoplasm Staging Oesophageal cancer Surgery Survival Transhiatal Transthoracic |
title | Short and long-term advantages of transhiatal and transthoracic oesophageal cancer resection |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T16%3A32%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Short%20and%20long-term%20advantages%20of%20transhiatal%20and%20transthoracic%20oesophageal%20cancer%20resection&rft.jtitle=European%20journal%20of%20surgical%20oncology&rft.au=Omloo,%20J.M.T&rft.date=2009-08-01&rft.volume=35&rft.issue=8&rft.spage=793&rft.epage=797&rft.pages=793-797&rft.issn=0748-7983&rft.eissn=1532-2157&rft_id=info:doi/10.1016/j.ejso.2008.10.005&rft_dat=%3Cproquest_cross%3E67425436%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67425436&rft_id=info:pmid/19010634&rft_els_id=S074879830801799X&rfr_iscdi=true |